Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation

World J Gastroenterol. 2020 May 7;26(17):2030-2039. doi: 10.3748/wjg.v26.i17.2030.

Abstract

Radiofrequency ablation (RFA) is very effective for eradication of flat Barrett's mucosa in dysplastic Barrett's esophagus after endoscopic resection of raised lesions. However, in a minority of the time, RFA may be ineffective at eradication of the Barrett's mucosa. Achieving complete eradication of intestinal metaplasia can be challenging in these patients. This review article focuses on the management of patients with dysplastic Barrett's esophagus refractory to RFA therapy. Management strategies discussed in this review include optimizing the RFA procedure, optimizing acid suppression (with medical, endoscopic, and surgical management), cryotherapy, hybrid argon plasma coagulation, and EndoRotor resection.

Keywords: Argon plasma coagulation; Cryotherapy; EndoRotor; High-grade dysplasia; Hybrid argon plasma coagulation; Low-grade dysplasia; Radiofrequency ablation.

Publication types

  • Review

MeSH terms

  • Antacids / therapeutic use
  • Argon Plasma Coagulation / methods
  • Barrett Esophagus / etiology
  • Barrett Esophagus / pathology
  • Barrett Esophagus / therapy*
  • Combined Modality Therapy / methods
  • Cryosurgery / methods
  • Esophageal Neoplasms / prevention & control*
  • Esophagoscopy / instrumentation
  • Esophagoscopy / methods*
  • Esophagus / diagnostic imaging
  • Esophagus / pathology*
  • Esophagus / surgery
  • Gastroesophageal Reflux / complications
  • Gastroesophageal Reflux / pathology
  • Gastroesophageal Reflux / therapy*
  • Humans
  • Radiofrequency Ablation / methods
  • Treatment Outcome

Substances

  • Antacids